10 0 2 0 2 B-lower_bound
% 2 3 2 3 I-lower_bound
or 4 6 4 6 O
more 7 11 7 11 O
increase 12 20 12 20 O
in 21 23 21 23 O
serum 24 29 24 29 B-clinical_variable
thyroglobulin 30 43 30 43 I-clinical_variable
( 44 45 44 45 O
on 45 47 45 47 O
thyroid 48 55 48 55 B-treatment
- 55 56 55 56 I-treatment
stimulating 56 67 56 67 I-treatment
hormone 68 75 68 75 I-treatment
[ 76 77 76 77 I-treatment
TSH]-suppression 77 93 77 93 I-treatment
) 93 94 93 94 O
within 95 101 95 101 O
9 102 103 102 103 B-upper_bound
months 104 110 104 110 I-upper_bound
of 111 113 111 113 O
RAI 114 117 114 117 B-treatment
treatment 118 127 118 127 I-treatment

Absolute 0 8 128 136 B-clinical_variable
neutrophil 9 19 137 147 I-clinical_variable
count 20 25 148 153 I-clinical_variable
( 26 27 154 155 I-clinical_variable
ANC 27 30 155 158 I-clinical_variable
) 30 31 158 159 I-clinical_variable
≥ 32 33 160 161 O
1,500 34 39 162 167 B-lower_bound
/ 39 40 167 168 I-lower_bound
mm^3 40 44 168 172 I-lower_bound

Age 0 3 173 176 B-age
≥ 4 5 177 178 O
18 6 8 179 181 B-lower_bound
years 9 14 182 187 I-lower_bound

CT 0 2 188 190 B-clinical_variable
must 3 7 191 195 O
be 8 10 196 198 O
performed 11 20 199 208 O
within 21 27 209 215 O
28 28 30 216 218 B-upper_bound
days 31 35 219 223 I-upper_bound
of 36 38 224 226 O
registration 39 51 227 239 O

Calculated 0 10 240 250 B-clinical_variable
creatinine 11 21 251 261 I-clinical_variable
clearance 22 31 262 271 I-clinical_variable
≥ 32 33 272 273 O
30 34 36 274 276 B-lower_bound
mL 37 39 277 279 I-lower_bound
/ 39 40 279 280 I-lower_bound
min 40 43 280 283 I-lower_bound

Cardiovascular 0 14 284 298 B-chronic_disease
disease 15 22 299 306 I-chronic_disease

Cerebrovascular 0 15 307 322 B-chronic_disease
accident 16 24 323 331 I-chronic_disease

Child 0 5 332 337 O
Pugh 6 10 338 342 O
Class 11 16 343 348 O
B 17 18 349 350 O
or 19 21 351 353 O
C 22 23 354 355 O
liver 24 29 356 361 B-chronic_disease
disease 30 37 362 369 I-chronic_disease

Chronic 0 7 370 377 B-chronic_disease
active 8 14 378 384 I-chronic_disease
hepatitis 15 24 385 394 I-chronic_disease

Chronic 0 7 395 402 B-treatment
concomitant 8 19 403 414 I-treatment
treatment 20 29 415 424 I-treatment
with 30 34 425 429 I-treatment
strong 35 41 430 436 I-treatment
CYP3A4 42 48 437 443 I-treatment
inducers 49 57 444 452 I-treatment

Chronic 0 7 453 460 O
concomitant 8 19 461 472 O
treatment 20 29 473 482 B-treatment
with 30 34 483 487 I-treatment
strong 35 41 488 494 I-treatment
inhibitors 42 52 495 505 I-treatment
of 53 55 506 508 I-treatment
cytochrome 56 66 509 519 I-treatment
P450 67 71 520 524 I-treatment
3A4 72 75 525 528 I-treatment
( 76 77 529 530 I-treatment
CYP3A4 77 83 530 536 I-treatment
) 83 84 536 537 I-treatment

Concomitant 0 11 538 549 O
medications 12 23 550 561 B-treatment

Creatinine 0 10 562 572 B-clinical_variable
≤ 11 12 573 574 O
1.5 13 16 575 578 B-upper_bound
mg 17 19 579 581 I-upper_bound
/ 19 20 581 582 I-upper_bound
dL 20 22 582 584 I-upper_bound

Eastern 0 7 585 592 B-clinical_variable
Cooperative 8 19 593 604 I-clinical_variable
Oncology 20 28 605 613 I-clinical_variable
Group 29 34 614 619 I-clinical_variable
( 35 36 620 621 I-clinical_variable
ECOG 36 40 621 625 I-clinical_variable
) 40 41 625 626 I-clinical_variable
Performance 42 53 627 638 I-clinical_variable
Status 54 60 639 645 I-clinical_variable
≤ 61 62 646 647 O
2 63 64 648 649 B-upper_bound

Fasting 0 7 650 657 B-clinical_variable
serum 8 13 658 663 I-clinical_variable
cholesterol 14 25 664 675 I-clinical_variable
≤ 26 27 676 677 O
300 28 31 678 681 B-upper_bound
mg 32 34 682 684 I-upper_bound
/ 34 35 684 685 I-upper_bound
dL 35 37 685 687 I-upper_bound

Grade 0 5 688 693 B-chronic_disease
3 6 7 694 695 I-chronic_disease
or 8 10 696 698 I-chronic_disease
4 11 12 699 700 I-chronic_disease
peripheral 13 23 701 711 I-chronic_disease
ischemia 24 32 712 720 I-chronic_disease

Grade 0 5 721 726 B-lower_bound
3 6 7 727 728 I-lower_bound
or 8 10 729 731 O
4 11 12 732 733 B-upper_bound
thromboembolic 13 27 734 748 B-chronic_disease
event 28 33 749 754 I-chronic_disease

Hepatitis 0 9 755 764 B-clinical_variable
B 10 11 765 766 I-clinical_variable
surface 12 19 767 774 I-clinical_variable
antigen 20 27 775 782 I-clinical_variable
( 28 29 783 784 I-clinical_variable
HBsAg 29 34 784 789 I-clinical_variable
) 34 35 789 790 I-clinical_variable
> 36 37 791 792 O
6 38 39 793 794 B-lower_bound
months 40 46 795 801 I-lower_bound

Liver 0 5 802 807 O
biopsy 6 12 808 814 O
showing 13 20 815 822 O
chronic 21 28 823 830 O
hepatitis 29 38 831 840 B-chronic_disease
with 39 43 841 845 O
moderate 44 52 846 854 O
or 53 55 855 857 O
severe 56 62 858 864 O
necroinﬂammation 63 79 865 881 B-chronic_disease

Liver 0 5 882 887 B-chronic_disease
disease 6 13 888 895 I-chronic_disease

Myocardial 0 10 896 906 B-chronic_disease
infarction 11 21 907 917 I-chronic_disease
or 22 24 918 920 O
unstable 25 33 921 929 B-chronic_disease
angina 34 40 930 936 I-chronic_disease

New 0 3 937 940 B-clinical_variable
York 4 8 941 945 I-clinical_variable
Heart 9 14 946 951 I-clinical_variable
Association 15 26 952 963 I-clinical_variable
grade 27 32 964 969 B-lower_bound
III 33 36 970 973 I-lower_bound
or 37 39 974 976 O
greater 40 47 977 984 O
congestive 48 58 985 995 B-chronic_disease
heart 59 64 996 1001 I-chronic_disease
failure 65 72 1002 1009 I-chronic_disease

No 0 2 1010 1012 O
Grade 3 8 1013 1018 B-lower_bound
3 9 10 1019 1020 I-lower_bound
or 11 13 1021 1023 O
4 14 15 1024 1025 B-upper_bound
hypertension 16 28 1026 1038 B-chronic_disease
( 29 30 1039 1040 O
systolic 30 38 1040 1048 B-clinical_variable
blood 39 44 1049 1054 I-clinical_variable
pressure 45 53 1055 1063 I-clinical_variable
[ 54 55 1064 1065 I-clinical_variable
BP 55 57 1065 1067 I-clinical_variable
] 57 58 1067 1068 I-clinical_variable
> 59 60 1069 1070 O
160 60 63 1070 1073 B-lower_bound
and 64 67 1074 1077 O
or 68 70 1078 1080 O
diastolic 71 80 1081 1090 B-clinical_variable
BP 81 83 1091 1093 I-clinical_variable
> 84 85 1094 1095 O
100 86 89 1096 1099 B-lower_bound
) 89 90 1099 1100 O
that 91 95 1101 1105 O
can 96 99 1106 1109 O
not 99 102 1109 1112 O
be 103 105 1113 1115 O
controlled 106 116 1116 1126 O
with 117 121 1127 1131 O
medication 122 132 1132 1142 B-treatment
prior 133 138 1143 1148 O
to 139 141 1149 1151 O
registration 142 154 1152 1164 O

No 0 2 1165 1167 O
history 3 10 1168 1175 O
of 11 13 1176 1178 O
any 14 17 1179 1182 O
of 18 20 1183 1185 O
the 21 24 1186 1189 O
following 25 34 1190 1199 O
≤ 35 36 1200 1201 O
6 37 38 1202 1203 B-upper_bound
months 39 45 1204 1210 I-upper_bound
of 46 48 1211 1213 O
registration 49 61 1214 1226 O

No 0 2 1227 1229 O
history 3 10 1230 1237 O
of 11 13 1238 1240 O
gastrointestinal 14 30 1241 1257 B-clinical_variable
fistula 31 38 1258 1265 I-clinical_variable
or 39 41 1266 1268 O
gastrointestinal 42 58 1269 1285 B-clinical_variable
perforation 59 70 1286 1297 I-clinical_variable
< 71 72 1298 1299 O
90 73 75 1300 1302 B-upper_bound
days 76 80 1303 1307 I-upper_bound
of 81 83 1308 1310 O
registration 84 96 1311 1323 O

No 0 2 1324 1326 O
history 3 10 1327 1334 O
of 11 13 1335 1337 O
intracranial 14 26 1338 1350 O
brain 27 32 1351 1356 B-cancer
metastasis 33 43 1357 1367 I-cancer

No 0 2 1368 1370 O
history 3 10 1371 1378 O
of 11 13 1379 1381 O
major 14 19 1382 1387 B-treatment
surgery 20 27 1388 1395 I-treatment
≤ 28 29 1396 1397 O
28 30 32 1398 1400 B-upper_bound
days 33 37 1401 1405 I-upper_bound
of 38 40 1406 1408 O
registration 41 53 1409 1421 O

No 0 2 1422 1424 O
known 3 8 1425 1430 O
history 9 16 1431 1438 O
of 17 19 1439 1441 O
prolonged 20 29 1442 1451 B-chronic_disease
QT 30 32 1452 1454 I-chronic_disease
syndrome 33 41 1455 1463 I-chronic_disease

No 0 2 1464 1466 O
prior 3 8 1467 1472 O
use 9 12 1473 1476 O
of 13 15 1477 1479 O
sorafenib 16 25 1480 1489 B-treatment
or 26 28 1490 1492 O
an 29 31 1493 1495 O
mammalian 32 41 1496 1505 B-treatment
target 42 48 1506 1512 I-treatment
of 49 51 1513 1515 I-treatment
rapamycin 52 61 1516 1525 I-treatment
( 62 63 1526 1527 I-treatment
mTOR 63 67 1527 1531 I-treatment
) 67 68 1531 1532 I-treatment
( 69 70 1533 1534 O
including 70 79 1534 1543 O
phosphoinositide 80 96 1544 1560 B-treatment
3 97 98 1561 1562 I-treatment
- 98 99 1562 1563 I-treatment
kinase 99 105 1563 1569 I-treatment
[ 106 107 1570 1571 I-treatment
PI3k 107 111 1571 1575 I-treatment
] 111 112 1575 1576 I-treatment
or 113 115 1577 1579 O
protein 116 123 1580 1587 B-treatment
kinase 124 130 1588 1594 I-treatment
B 131 132 1595 1596 I-treatment
[ 133 134 1597 1598 I-treatment
AKT 134 137 1598 1601 I-treatment
] 137 138 1601 1602 I-treatment
) 138 139 1602 1603 I-treatment
inhibitor 140 149 1604 1613 I-treatment
for 150 153 1614 1617 O
the 154 157 1618 1621 O
treatment 158 167 1622 1631 B-treatment
of 168 170 1632 1634 O
thyroid 171 178 1635 1642 B-cancer
cancer 179 185 1643 1649 I-cancer

Not 0 3 1650 1653 B-pregnancy
pregnant 4 12 1654 1662 I-pregnancy

Patients 0 8 1663 1671 O
on 9 11 1672 1674 O
strong 12 18 1675 1681 B-treatment
CYP3A4 19 25 1682 1688 I-treatment
inhibitors 26 36 1689 1699 I-treatment
must 37 41 1700 1704 O
discontinue 42 53 1705 1716 O
the 54 57 1717 1720 O
drug 58 62 1721 1725 O
for 63 66 1726 1729 O
14 67 69 1730 1732 B-upper_bound
days 70 74 1733 1737 I-upper_bound
prior 75 80 1738 1743 I-upper_bound
to 81 83 1744 1746 O
registration 84 96 1747 1759 O
on 97 99 1760 1762 O
the 100 103 1763 1766 O
study 104 109 1767 1772 O

Patients 0 8 1773 1781 O
requiring 9 18 1782 1791 O
anticoagulation 19 34 1792 1807 B-treatment
must 35 39 1808 1812 O
be 40 42 1813 1815 O
on 43 45 1816 1818 O
stable 46 52 1819 1825 O
dose 53 57 1826 1830 O
of 58 60 1831 1833 O
medication 61 71 1834 1844 B-treatment
prior 72 77 1845 1850 O
to 78 80 1851 1853 O
registration 81 93 1854 1866 O

Persistent 0 10 1867 1877 O
or 11 13 1878 1880 O
intermittent 14 26 1881 1893 O
elevation 27 36 1894 1903 O
in 37 39 1904 1906 O
alanine 40 47 1907 1914 B-clinical_variable
aminotransferase 48 64 1915 1931 I-clinical_variable
( 65 66 1932 1933 I-clinical_variable
ALT)/aspartate 66 80 1933 1947 I-clinical_variable
aminotransferase 81 97 1948 1964 I-clinical_variable
( 98 99 1965 1966 I-clinical_variable
AST 99 102 1966 1969 I-clinical_variable
) 102 103 1969 1970 I-clinical_variable
levels 104 110 1971 1977 I-clinical_variable

Platelet 0 8 1978 1986 B-clinical_variable
count 9 14 1987 1992 I-clinical_variable
≥ 15 16 1993 1994 O
100,000 17 24 1995 2002 B-lower_bound
/ 24 25 2002 2003 I-lower_bound
mm^3 25 29 2003 2007 I-lower_bound

Presence 0 8 2008 2016 O
of 9 11 2017 2019 O
fluorodeoxyglucose 12 30 2020 2038 B-treatment
( 31 32 2039 2040 I-treatment
FDG 32 35 2040 2043 I-treatment
) 35 36 2043 2044 I-treatment
avid 37 41 2045 2049 O
metastatic 42 52 2050 2060 B-cancer
lesions 53 60 2061 2068 I-cancer
on 61 63 2069 2071 O
positron 64 72 2072 2080 B-treatment
emission 73 81 2081 2089 I-treatment
tomography 82 92 2090 2100 I-treatment
( 93 94 2101 2102 I-treatment
PET)/CT 94 101 2102 2109 I-treatment
scan 102 106 2110 2114 I-treatment
( 107 108 2115 2116 O
standardized 108 120 2116 2128 B-clinical_variable
uptake 121 127 2129 2135 I-clinical_variable
values 128 134 2136 2142 I-clinical_variable
[ 135 136 2143 2144 I-clinical_variable
SUV]max 136 143 2144 2151 I-clinical_variable
> 144 145 2152 2153 O
5 146 147 2154 2155 B-lower_bound
of 148 150 2156 2158 O
any 151 154 2159 2162 O
single 155 161 2163 2169 O
lesion 162 168 2170 2176 O
) 168 169 2176 2177 O

Prior 0 5 2178 2183 B-treatment
RAI 6 9 2184 2187 I-treatment
therapy 10 17 2188 2195 I-treatment
is 18 20 2196 2198 O
allowed 21 28 2199 2206 O
if 29 31 2207 2209 O
≥ 32 33 2210 2211 O
90 34 36 2212 2214 B-lower_bound
days 37 41 2215 2219 I-lower_bound
prior 42 47 2220 2225 I-lower_bound
to 48 50 2226 2228 O
registration 51 63 2229 2241 O
on 64 66 2242 2244 O
this 67 71 2245 2249 O
protocol 72 80 2250 2258 O
and 81 84 2259 2262 O
evidence 85 93 2263 2271 O
of 94 96 2272 2274 O
progression 97 108 2275 2286 O
( 109 110 2287 2288 O
as 110 112 2288 2290 O
defined 113 120 2291 2298 O
above 121 126 2299 2304 O
) 126 127 2304 2305 O
has 128 131 2306 2309 O
been 132 136 2310 2314 O
documented 137 147 2315 2325 O
in 148 150 2326 2328 O
the 151 154 2329 2332 O
interim 155 162 2333 2340 O
( 163 164 2341 2342 O
a 164 165 2342 2343 O
diagnostic 166 176 2344 2354 O
study 177 182 2355 2360 O
using 183 188 2361 2366 O
< 189 190 2367 2368 O
10 191 193 2369 2371 B-upper_bound
mCi 194 197 2372 2375 I-upper_bound
of 198 200 2376 2378 O
RAI 201 204 2379 2382 O
is 205 207 2383 2385 O
not 208 211 2386 2389 O
considered 212 222 2390 2400 O
RAI 223 226 2401 2404 O
therapy 227 234 2405 2412 O
) 234 235 2412 2413 O

Prior 0 5 2414 2419 B-treatment
chemotherapy 6 18 2420 2432 I-treatment
is 19 21 2433 2435 O
allowed 22 29 2436 2443 O
if 30 32 2444 2446 O
≥ 33 34 2447 2448 O
28 35 37 2449 2451 B-lower_bound
days 38 42 2452 2456 I-lower_bound
prior 43 48 2457 2462 I-lower_bound
to 49 51 2463 2465 O
registration 52 64 2466 2478 O
on 65 67 2479 2481 O
this 68 72 2482 2486 O
protocol 73 81 2487 2495 O

Prior 0 5 2496 2501 B-treatment
radiation 6 15 2502 2511 I-treatment
therapy 16 23 2512 2519 I-treatment
to 24 26 2520 2522 O
the 27 30 2523 2526 O
non 31 34 2527 2530 O
- 34 35 2530 2531 O
index 35 40 2531 2536 O
lesions 41 48 2537 2544 O
is 49 51 2545 2547 O
allowed 52 59 2548 2555 O
if 60 62 2556 2558 O
≥ 63 64 2559 2560 O
28 65 67 2561 2563 B-lower_bound
days 68 72 2564 2568 I-lower_bound
prior 73 78 2569 2574 I-lower_bound
to 79 81 2575 2577 O
registration 82 94 2578 2590 O
on 95 97 2591 2593 O
this 98 102 2594 2598 O
protocol 103 111 2599 2607 O

Progressive 0 11 2608 2619 O
disease 12 19 2620 2627 O
defined 20 27 2628 2635 O
by 28 30 2636 2638 O
RECIST 31 37 2639 2645 B-clinical_variable
criteria 38 46 2646 2654 I-clinical_variable
≤ 47 48 2655 2656 O
14 49 51 2657 2659 B-upper_bound
months 52 58 2660 2666 I-upper_bound

RAI 0 3 2667 2670 B-cancer
- 3 4 2670 2671 I-cancer
avid 4 8 2671 2675 I-cancer
metastatic 9 19 2676 2686 I-cancer
lesion 20 26 2687 2693 I-cancer
which 27 32 2694 2699 O
remained 33 41 2700 2708 O
stable 42 48 2709 2715 O
in 49 51 2716 2718 O
size 52 56 2719 2723 O
or 57 59 2724 2726 O
progressed 60 70 2727 2737 O
despite 71 78 2738 2745 O
RAI 79 82 2746 2749 B-treatment
treatment 83 92 2750 2759 I-treatment
within 93 99 2760 2766 O
9 100 101 2767 2768 B-upper_bound
months 102 108 2769 2775 I-upper_bound
of 109 111 2776 2778 O
RAI 112 115 2779 2782 O
treatment 116 125 2783 2792 O

Radioactive 0 11 2793 2804 B-treatment
iodine 12 18 2805 2811 I-treatment
( 19 20 2812 2813 I-treatment
RAI 20 23 2813 2816 I-treatment
) 23 24 2816 2817 I-treatment

Serum 0 5 2818 2823 B-clinical_variable
glutamic 6 14 2824 2832 I-clinical_variable
oxaloacetic 15 26 2833 2844 I-clinical_variable
transaminase 27 39 2845 2857 I-clinical_variable
( 40 41 2858 2859 I-clinical_variable
SGOT 41 45 2859 2863 I-clinical_variable
) 45 46 2863 2864 I-clinical_variable
( 47 48 2865 2866 I-clinical_variable
AST 48 51 2866 2869 I-clinical_variable
) 51 52 2869 2870 I-clinical_variable
≤ 53 54 2871 2872 O
2.5 55 58 2873 2876 B-upper_bound
x 59 60 2877 2878 I-upper_bound
ULN 61 64 2879 2882 I-upper_bound

Serum 0 5 2883 2888 O
hepatitis 6 15 2889 2898 B-chronic_disease
B 16 17 2899 2900 I-chronic_disease
virus 18 23 2901 2906 I-chronic_disease
( 24 25 2907 2908 I-chronic_disease
HBV 25 28 2908 2911 I-chronic_disease
) 28 29 2911 2912 I-chronic_disease
deoxyribonucleic 30 46 2913 2929 O
acid 47 51 2930 2934 O
( 52 53 2935 2936 O
DNA 53 56 2936 2939 O
) 56 57 2939 2940 O
20,000 58 64 2941 2947 O
IU 65 67 2948 2950 O
/ 67 68 2950 2951 O
ml 68 70 2951 2953 O
( 71 72 2954 2955 O
105 72 75 2955 2958 B-upper_bound
copies 76 82 2959 2965 I-upper_bound
/ 82 83 2965 2966 I-upper_bound
ml 83 85 2966 2968 I-upper_bound
) 85 86 2968 2969 O
, 86 87 2969 2970 O
lower 88 93 2971 2976 O
values 94 100 2977 2983 O
2,000 101 106 2984 2989 O
- 106 107 2989 2990 O
20,000 107 113 2990 2996 O
IU 114 116 2997 2999 O
/ 116 117 2999 3000 O
ml 117 119 3000 3002 O
( 120 121 3003 3004 O
104 121 124 3004 3007 B-lower_bound
- 124 125 3007 3008 O
105 125 128 3008 3011 O
copies 129 135 3012 3018 O
/ 135 136 3018 3019 O
ml 136 138 3019 3021 O
) 138 139 3021 3022 O
are 140 143 3023 3026 O
often 144 149 3027 3032 O
seen 150 154 3033 3037 O
in 155 157 3038 3040 O
hepatitis 158 167 3041 3050 O
B 168 169 3051 3052 O
e 170 171 3053 3054 O
antigen 172 179 3055 3062 O
( 180 181 3063 3064 O
HBeAg)-negative 181 196 3064 3079 O
chronic 197 204 3080 3087 O
hepatitis 205 214 3088 3097 O
B 215 216 3098 3099 O

Total 0 5 3100 3105 B-clinical_variable
bilirubin 6 15 3106 3115 I-clinical_variable
≤ 16 17 3116 3117 O
1.5 18 21 3118 3121 B-upper_bound
x 22 23 3122 3123 I-upper_bound
upper 24 29 3124 3129 I-upper_bound
limits 30 36 3130 3136 I-upper_bound
of 37 39 3137 3139 I-upper_bound
normal 40 46 3140 3146 I-upper_bound
( 47 48 3147 3148 I-upper_bound
ULN 48 51 3148 3151 I-upper_bound
) 51 52 3151 3152 I-upper_bound

a 0 1 3153 3154 O
negative 2 10 3155 3163 B-pregnancy
serum 11 16 3164 3169 I-pregnancy
pregnancy 17 26 3170 3179 I-pregnancy
test 27 31 3180 3184 O
done 32 36 3185 3189 O
≤ 37 38 3190 3191 O
7 39 40 3192 3193 B-upper_bound
days 41 45 3194 3198 I-upper_bound
prior 46 51 3199 3204 I-upper_bound
to 52 54 3205 3207 O
registration 55 67 3208 3220 O

discontinue 0 11 3221 3232 O
the 12 15 3233 3236 O
drug 16 20 3237 3241 O
14 21 23 3242 3244 B-upper_bound
days 24 28 3245 3249 I-upper_bound
prior 29 34 3250 3255 I-upper_bound
to 35 37 3256 3258 O
the 38 41 3259 3262 O
start 42 47 3263 3268 O
of 48 50 3269 3271 O
study 51 56 3272 3277 B-treatment
treatment 57 66 3278 3287 I-treatment

have 0 4 3288 3292 O
10 5 7 3293 3295 O
representative 8 22 3296 3310 O
hematoxylin 23 34 3311 3322 O
and 35 38 3323 3326 O
eosin 39 44 3327 3332 O
( 45 46 3333 3334 O
H&E 46 49 3334 3337 O
) 49 50 3337 3338 O
stained 51 58 3339 3346 O
thyroid 59 66 3347 3354 O
tissue 67 73 3355 3361 O
slides 74 80 3362 3368 O
OR 81 83 3369 3371 O
tumor 84 89 3372 3377 B-cancer
block 90 95 3378 3383 O
available 96 105 3384 3393 O
for 106 109 3394 3397 O
submission 110 120 3398 3408 O
to 121 123 3409 3411 O
central 124 131 3412 3419 O
pathology 132 141 3420 3429 O
review 142 148 3430 3436 O

have 0 4 3437 3441 O
measurable 5 15 3442 3452 O
disease 16 23 3453 3460 O
by 24 26 3461 3463 O
Response 27 35 3464 3472 O
Evaluation 36 46 3473 3483 O
Criteria 47 55 3484 3492 O
In 56 58 3493 3495 O
Solid 59 64 3496 3501 O
Tumors 65 71 3502 3508 O
( 72 73 3509 3510 O
RECIST 73 79 3510 3516 O
) 79 80 3516 3517 O
criteria 81 89 3518 3526 O
, 89 90 3526 3527 O
defined 91 98 3528 3535 O
as 99 101 3536 3538 O
at 102 104 3539 3541 O
least 105 110 3542 3547 O
one 111 114 3548 3551 B-lower_bound
lesion 115 121 3552 3558 O
that 122 126 3559 3563 O
can 127 130 3564 3567 O
be 131 133 3568 3570 O
accurately 134 144 3571 3581 O
measured 145 153 3582 3590 O
in 154 156 3591 3593 O
at 157 159 3594 3596 O
least 160 165 3597 3602 O
one 166 169 3603 3606 O
dimension 170 179 3607 3616 O
( 180 181 3617 3618 O
longest 181 188 3618 3625 O
diameter 189 197 3626 3634 O
to 198 200 3635 3637 O
be 201 203 3638 3640 O
recorded 204 212 3641 3649 O
) 212 213 3649 3650 O
as 214 216 3651 3653 O
≥ 217 218 3654 3655 O
20 219 221 3656 3658 B-lower_bound
mm 222 224 3659 3661 I-lower_bound
with 225 229 3662 3666 O
conventional 230 242 3667 3679 O
techniques 243 253 3680 3690 O
or 254 256 3691 3693 O
as 257 259 3694 3696 O
≥ 260 261 3697 3698 O
10 262 264 3699 3701 B-lower_bound
mm 265 267 3702 3704 I-lower_bound
with 268 272 3705 3709 O
spiral 273 279 3710 3716 B-treatment
computed 280 288 3717 3725 I-treatment
tomography 289 299 3726 3736 I-treatment
( 300 301 3737 3738 I-treatment
CT 301 303 3738 3740 I-treatment
) 303 304 3740 3741 I-treatment
scan 305 309 3742 3746 I-treatment

have 0 4 3747 3751 O
metastatic 5 15 3752 3762 B-cancer
disease 16 23 3763 3770 O
or 24 26 3771 3773 O
locally 27 34 3774 3781 O
advanced 35 43 3782 3790 O
unresectable 44 56 3791 3803 O
disease 57 64 3804 3811 O

have 0 4 3812 3816 O
received 5 13 3817 3825 O
any 14 17 3826 3829 O
number 18 24 3830 3836 O
of 25 27 3837 3839 O
prior 28 33 3840 3845 B-treatment
lines 34 39 3846 3851 I-treatment
of 40 42 3852 3854 I-treatment
therapy 43 50 3855 3862 I-treatment

have 0 4 3863 3867 O
received 5 13 3868 3876 O
prior 14 19 3877 3882 B-treatment
radiation 20 29 3883 3892 I-treatment
therapy 30 37 3893 3900 I-treatment
to 38 40 3901 3903 O
index 41 46 3904 3909 B-clinical_variable
lesions 47 54 3910 3917 I-clinical_variable
≥ 55 56 3918 3919 O
28 57 59 3920 3922 B-lower_bound
days 60 64 3923 3927 I-lower_bound
prior 65 70 3928 3933 I-lower_bound
to 71 73 3934 3936 O
registration 74 86 3937 3949 O
on 87 89 3950 3952 O
this 90 94 3953 3957 O
protocol 95 103 3958 3966 O
if 104 106 3967 3969 O
there 107 112 3970 3975 O
has 113 116 3976 3979 O
been 117 121 3980 3984 O
documented 122 132 3985 3995 O
progression 133 144 3996 4007 O
by 145 147 4008 4010 O
RECIST 148 154 4011 4017 O
criteria 155 163 4018 4026 O

must 0 4 4027 4031 O
have 5 9 4032 4036 O
histopathologically 10 29 4037 4056 O
confirmed 30 39 4057 4066 O
Hürthle 40 47 4067 4074 B-cancer
cell 48 52 4075 4079 I-cancer
thyroid 53 60 4080 4087 I-cancer
cancer 61 67 4088 4094 I-cancer
by 68 70 4095 4097 O
central 71 78 4098 4105 O
review 79 85 4106 4112 O

who 0 3 4113 4116 O
have 4 8 4117 4121 O
received 9 17 4122 4130 O
greater 18 25 4131 4138 O
than 26 30 4139 4143 O
600 31 34 4144 4147 B-lower_bound
mCi 35 38 4148 4151 I-lower_bound
of 39 41 4152 4154 O
radioactive 42 53 4155 4166 B-treatment
iodine 54 60 4167 4173 I-treatment
in 61 63 4174 4176 O
their 64 69 4177 4182 O
lifetime 70 78 4183 4191 O

women 0 5 4192 4197 B-gender
of 6 8 4198 4200 O
childbearing 9 21 4201 4213 O
potential 22 31 4214 4223 O

